Medical imaging reagents are an inextricable part of industries such as biotechnology, diagnostics, pharmaceuticals, and life sciences. The report on medical imaging reagents analyzes the market using a four pronged approach: Class, technology type, application, and geographical region. The report analyzes the market for each segment based on its past, current and forecasted revenues (USD million). The report also estimates the percentage of the compounded annual growth rate (CAGR) for each of these segments for the period 2013 to 2019, with 2012 being the base year.
Besides critical market indicators and trends, the report also offers a deeper understanding of the prevailing and forecasted market dynamics, which include: drivers, restraints, trends, and opportunities. The report’s market overview section focuses on a qualitative analysis of the medical imaging reagents market. This section also carries an evaluation of the bargaining power of buyers and suppliers as well as threat from alternatives and new entrants using the Porter’s five forces analysis model.
Overview of the Medical Imaging Reagents Market
The global medical imaging reagents market has received an impetus from a rise in the incidence of cardiovascular diseases and cancer. Medical imaging reagents are unique chemical compounds in that they help diagnosticians and medical care providers determine the malignancy or benignancy of a tumor. Reagents have been found to be a fairly reliable method of establishing the presence of metastatic cancer in a patient. The presence of reagents during medical imaging helps better identify suspicious growths and tumors in the body.
This report segments the imaging reagents market based on three aspects: Class, applications, technology type, and geographical region. Based on products, the market has been segmented into the following types of reagents: Contrast, optical and nuclear reagents. On the basis of technology, the segments analyzed in the report include: Nanoparticles, radiopharmaceuticals, fluorescent proteins, fluorescent dyes, quantum dots, and probes.
Similarly, on the basis of applications, the medical imaging reagents market has been split into three distinct segments: Diagnostics, research and development, and drug discovery and development.
In recent years, the use of technologies such as biochips, polymerase chain reaction (PCR), DNA sequencing, and hybrid imaging modalities has caught on. All of these technologies rely on medical imaging reagents that are highly sensitive, so as to produce enhanced images. As a result, the growth of the medical imaging reagents market will be directly proportional to the deployment of innovative technologies in healthcare and diagnostic technologies market.
The most influential drivers in the medical imaging reagents market are: A palpable increase in the demand for functional imaging and diagnostic technologies, the sheer compatibility of reagents in various applications and an increased emphasis on patient safety. On the other hand, a short supply of materials and high development cost of reagents could adversely impact the market in the coming years. To counter the impact of these market restraints, companies could focus on opportunities such as development of nuclear products for personalized therapies.
Companies Mentioned in the Medical Imaging Reagents Market Report
The Company Profiles section of this report analyzes players such as: Bayer Healthcare AG, GE Healthcare, Bracco Imaging SpA, Lantheus Medical Imaging, Inc., Siemens Healthcare, Mallinckrodt Pharmaceuticals, and Thermo Fisher Scientific, Inc.
Global Medical Imaging Reagents Market Segmentation, by Class
Global Medical Imaging Reagents Market Segmentation, by Technology
Global Medical Imaging Reagents Market Segmentation, by Application
Global Medical Imaging Reagents Market Segmentation, by Geography
This report gives you access to decisive data such as:
Key highlights of this report
MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.Get A Free Custom Research Quote